Riverside First in the World to Offer New Life-Changing Treatment for MS

Medical staff at OhioHealth's Neuroscience Center at Riverside Methodist Hospital became the first in the world to treat patients with a new FDA drug called Ocrevus in the battle against multiple sclerosis.

The significance of the drug lies in how it can slow what's called primary progressive multiple sclerosis. The manufacturer, Genentech, says it is the first and only disease-modifying therapy for primary progressive multiple sclerosis or PPMS.

Watch the WBNS 10-TV story about the drug above. 

To learn more about OhioHealth's approach to Multiple Sclerosis care and treatment, check out our Multiple Sclerosis page.